Zhuhai Rundu Pharmaceutical Co Ltd Class A
Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, qu… Read more
Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.036x
Based on the latest financial reports, Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923) has a cash flow conversion efficiency ratio of 0.036x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥37.78 Million) by net assets (CN¥1.05 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhuhai Rundu Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhuhai Rundu Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhuhai Rundu Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhuhai Rundu Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
US Century Bank
NASDAQ:USCB
|
0.095x |
|
Moso Power Supply Technology Co Ltd
SHE:002660
|
0.057x |
|
Guangdong Huiyun Titanium Industry
SHE:300891
|
-0.002x |
|
Qingdao NovelBeam Technology Co. Ltd. A
SHG:688677
|
0.013x |
|
Hengerda New Materials (Fujian) Co. Ltd.
SHE:300946
|
N/A |
|
CLS Holdings plc
PINK:CLIHF
|
N/A |
|
PT Hanjaya Mandala Sampoerna Tbk
PINK:PHJMF
|
0.130x |
|
Firstrand Ltd
JSE:FSR
|
0.188x |
Annual Cash Flow Conversion Efficiency for Zhuhai Rundu Pharmaceutical Co Ltd Class A (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhuhai Rundu Pharmaceutical Co Ltd Class A from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.15 Billion | CN¥211.19 Million | 0.183x | +25.17% |
| 2023-12-31 | CN¥1.18 Billion | CN¥172.68 Million | 0.146x | +29.73% |
| 2022-12-31 | CN¥1.20 Billion | CN¥135.01 Million | 0.113x | -39.03% |
| 2021-12-31 | CN¥1.11 Billion | CN¥205.91 Million | 0.185x | -23.22% |
| 2020-12-31 | CN¥1.04 Billion | CN¥250.35 Million | 0.241x | +49.86% |
| 2019-12-31 | CN¥940.29 Million | CN¥151.30 Million | 0.161x | -11.85% |
| 2018-12-31 | CN¥871.29 Million | CN¥159.04 Million | 0.183x | +53.97% |
| 2017-12-31 | CN¥488.84 Million | CN¥57.95 Million | 0.119x | -49.82% |
| 2016-12-31 | CN¥398.19 Million | CN¥94.07 Million | 0.236x | +46.41% |
| 2015-12-31 | CN¥310.72 Million | CN¥50.14 Million | 0.161x | -23.98% |
| 2014-12-31 | CN¥273.31 Million | CN¥58.01 Million | 0.212x | +58.34% |
| 2013-12-31 | CN¥236.29 Million | CN¥31.67 Million | 0.134x | -61.82% |
| 2012-12-31 | CN¥199.43 Million | CN¥70.01 Million | 0.351x | +72.18% |
| 2011-12-31 | CN¥165.33 Million | CN¥33.71 Million | 0.204x | -- |